ARTICLE | Company News
Scripps granted BlinkBio an option to exclusively license Dual Variable Domain-Fab (DVD-Fab) technology, which the biotech will use to develop Tunable Drug Conjugates (TDCs), initially to treat cancer...
Scripps granted BlinkBio an option to exclusively license Dual Variable Domain-Fab (DVD-Fab) technology, which the biotech will use to develop Tunable Drug Conjugates (TDCs), initially to treat cancer...